Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 9, 2015, Pages

  Foo, Valencia Hui Xian ^a   Perera, Shamira A ^b   Htoon, Hla M ^c   Welsbie, Derek S ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; MITOMYCIN;

ARTICLE; BEST CORRECTED VISUAL ACUITY; DRUG EFFICACY; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OUTCOME ASSESSMENT; PRIMARY GLAUCOMA; PRIORITY JOURNAL; SECONDARY GLAUCOMA; SYSTEMATIC REVIEW; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 85026435799     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011875     Document Type: Article

References (42)

1. American National Standard for Ophthalmics. ANSI Z80.27 Ophthalmics - aqueous shunts for glaucoma application. American Optometric Association 2001 (R2011).
2. Azuara-Blanco A, Moster MR, Wilson RP, Schmidt CM. Simultaneous use of mitomycin-C with Baerveldt implantation. Ophthalmic Surgery and Lasers 1997;28(12):992-7.
3. Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. British Journal of Ophthalmology 2001;85(6):689-95.
4. Cantor L, Burgoyne J, Sanders S, Bhavnani V, Hoop J, Brizendine E. The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. Journal of Glaucoma 1998;7(4):240-6.
5. Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology 2004;111(6):1071-6.
6. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
7. Duan X, Jiang Y, Qing G. Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin-C for refractory glaucoma. Yan Ke Xue Bao Bian Ji Bu 2003;19(2):81-5.
8. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. American Journal of Ophthalmology 2012;153(5):804-14.
9. Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. American Journal of Ophthalmology 2012;153(5):789-803.
10. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
11. Grade Working Group. www.gradeworkinggroup.org/ (accessed 15 May 2015).
12. Green E, Wilkins M, Bunce C, Wormald R. 5-Fluorouracil for glaucoma surgery. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD001132.pub2]
13. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
14. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology 2002;120(6):701-13.
15. Khaw P, Sherwood MB, MacKay SA, Rossi MJ, Schulz G. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Archives of Ophthalmology 1992;110(8):1150-4.
16. Kook MS, Yoon J, Kim J, Lee MS. Clinical results of Ahmed glaucoma valve implantation in refractory glaucoma with adjunctive mitomycin C. Ophthalmic Surgery and Lasers 2000;31(2):100-6.
17. Lee D, Shin DH, Birt CM, Kim C, Kupin TH, Olivier MM, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1997;104(12):2126-35.
18. Lewis TL, Fingeret M. Definition and classifications of glaucomas. Primary Care of the Glaucomas. 2nd Edition. New York: McGraw-Hill, 2001:3-5.
19. Mietz H, Krieglstein GK. Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations. International Ophthalmology 1995;19(1):51-56.
20. MInckler DS, Shammas A, Wilcox M, Ogden TE. Experimental studies of aqueous filtration using the Molteno implant. Transactions of the American Ophthalmological Society 1987;85:368-92.
21. Minckler DS. Glaucoma drainage devices, horsehair to silicone. In: Van Buskirk EM, Shields MB editor(s). 100 Years of Progress in Glaucoma. Philadelphia: Lippincott-Rave, 1997:287-92.
22. Minckler D, Vedula SS, Li T, Mathew M, Ayyala R, Francis B. Aqueous shunts for glaucoma. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD004918.pub2]
23. Minckler DA, Francis BA, Hodapp EA, Jampel HD, Lin SC, Samples JR, et al. Aqueous shunts in glaucoma OTA. A report by the American Academy of Ophthalmology Ophthalmic Technology Assessment Committee Glaucoma Panel. Ophthalmology 2008;115:1089-98.
24. Molteno AC. The optimal design of drainage implants for glaucoma. Transactions of the Ophthalmological Society of New Zealand 1981;33:39-41.
25. Molteno AC, Bevin TH, Herbison P, Houliston MJ. Otago glaucoma surgery outcome study: long-term follow-up of cases of primary glaucoma with additional risk factors drained by Molteno implants. Ophthalmology 2001;108(12):2193-200.
26. Molteno AC, Fucik M, Dempster AG, Bevin TH. Otago glaucoma surgery outcome study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology 2003;110(11):2198-206.
27. Perkins TW, Cardakli UF, Eisele JR, Kaufman PL, Heatley GA. Adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1995;102(1):91-7.
28. Prata JA Jr, Mérmoud A, LaBree L, Minckler DS. In vitro and in vivo flow characteristics of glaucoma drainage implants. Ophthalmology 1995;102(6):894-904.
29. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006;90(3):262-7.
30. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology 2007;114(12):2265-70.
31. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
32. Robin AL, Ramakrishnan R, Krishnadas R, Smith SD, Katz JD, Selvaraj S, et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Archives of Ophthalmology 1997;115(8):969-74.
33. Rosenberg LF, Krupin T. Implants in glaucoma surgery. In: Ritch R, Shields MB, Krupin T editor(s). The Glaucomas. St. Louis: Mosby, 1996:1783-807.
34. Sari A, Onol M, Ozdek S, Ozogul C, Hasanreisoglu B. Effect of mitomycin C on ciliary body and intraocular pressure with various application depths: an experimental study. Clinical and Experimental Ophthalmology 2005;33(2):169-75.
35. Schocket SS. Investigations of the reasons for success and failure in the anterior shunt-to-the-encircling-band procedure in the treatment of refractory glaucoma. Transactions of the American Ophthalmological Society 1986;84:743-98.
36. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95(6):813-21.
37. Trible JR, Brown DB. Occlusive ligature and standardized fenestration of a Baerveldt tube with and without antimetabolites for early postoperative intraocular pressure control. Ophthalmology 1998;105(12):2243-50.
38. Wang X, Wang R, Coleman A. Device modified trabeculectomy for glaucoma. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD010472]
39. Weinreb RN, Khaw PT. Primary open-angle glaucoma. The Lancet 2004;363(9422):1711-20.
40. Wilcox MJ, Minckler DS, Odgen TE. Pathophysiology of artificial aqueous drainage in primate eyes with Molteno implants. Journal of Glaucoma 1994;3(2):140-51.
41. Wilkins M, Indar A, Wormald R. Intraoperative Mitomycin C for glaucoma surgery. Cochrane Database of Systematic Reviews 2010, Issue 2. [DOI: 10.1002/14651858.CD002897.pub2]
42. Wilson MR, Mendis U, Paliwal A, Haynatzka V. Long-term follow-up of primary glaucoma surgery with Ahmed Glaucoma Valve implant versus trabeculectomy. American Journal of Ophthalmology 2003;136(3):464-70.